Paper34375141
Why Are Patients Switching from Tenofovir Disoproxil Fumarate/Emtricitabine (Truvada) to Tenofovir Alafenamide/Emtricitabine (Descovy) for Pre-Exposure Prophylaxis?
D'Angelo AB and 4 others. AIDS Patient Care STDS, 2021. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Why Are Patients Switching from Tenofovir Disoproxil Fumarate/Emtricitabine (Truvada) to Tenofovir Alafenamide/Emtricitabine (Descovy) for Pre-Exposure Prophylaxis? Papers, record 34375141. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34375141
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| HIV Infections | Major topic |
| Pre-Exposure Prophylaxis | Major topic |
| Adenine | |
| Alanine | |
| Cohort Studies | |
| Emtricitabine | |
| Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | |
| Humans | |
| Male | |
| Tenofovir |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| UH3 AI133675 | NIAID NIH HHS | United States | UH3AI133675 | PubMed and NIH |
Source NIH RePORTER
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27540015 | Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study. | BMJ | 2016 | https://conductscience.org/library/papers/27540015 | PubMed |
| 2 | 20945262 | All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving. | Am J Bioeth | 2010 | https://conductscience.org/library/papers/20945262 | PubMed |
| 3 | 32711800 | Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. | Lancet | 2020 | https://conductscience.org/library/papers/32711800 | PubMed |
| 4 | 31742421 | Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting. | AIDS Patient Care STDS | 2019 | https://conductscience.org/library/papers/31742421 | PubMed |
| 5 | 27322350 | Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. | JAMA Intern Med | 2016 | https://conductscience.org/library/papers/27322350 | PubMed |
| 6 | 24210060 | Effectiveness of academic detailing to optimize medication prescribing behaviour of family physicians. | J Pharm Pharm Sci | 2013 | https://conductscience.org/library/papers/24210060 | PubMed |
| 7 | 22852138 | FDA paves the way for pre-exposure HIV prophylaxis. | Lancet | 2012 | https://conductscience.org/library/papers/22852138 | PubMed |
| 8 | 31412928 | Changing prescribing behaviours with educational outreach: an overview of evidence and practice. | BMC Med Educ | 2019 | https://conductscience.org/library/papers/31412928 | PubMed |
| 9 | 32654021 | Economic, Mental Health, HIV Prevention and HIV Treatment Impacts of COVID-19 and the COVID-19 Response on a Global Sample of Cisgender Gay Men and Other Men Who Have Sex with Men. | AIDS Behav | 2021 | https://conductscience.org/library/papers/32654021 | PubMed |
| 10 | 31896287 | Maximizing Response Rates to Ads for Free At-Home HIV Testing on a Men-for-Men Geosocial Sexual Networking App: Lessons Learned and Implications for Researchers and Providers. | Health Educ Behav | 2020 | https://conductscience.org/library/papers/31896287 | PubMed |
| 11 | 22636826 | Effect of physician payment disclosure laws on prescribing. | Arch Intern Med | 2012 | https://conductscience.org/library/papers/22636826 | PubMed |
| 12 | 30515300 | How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP. | J Virus Erad | 2018 | https://conductscience.org/library/papers/30515300 | PubMed |
| 13 | 27562781 | Two years of sunshine: has openness about payments reduced industry influence in healthcare? | BMJ | 2016 | https://conductscience.org/library/papers/27562781 | PubMed |
| 14 | 2104640 | Principles of educational outreach ('academic detailing') to improve clinical decision making. | JAMA | 1990 | https://conductscience.org/library/papers/2104640 | PubMed |
| 15 | 27856120 | Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States. | Soc Sci Med | 2017 | https://conductscience.org/library/papers/27856120 | PubMed |
| 16 | 31182379 | Recruiting vulnerable populations to participate in HIV prevention research: findings from the Together 5000 cohort study. | Ann Epidemiol | 2019 | https://conductscience.org/library/papers/31182379 | PubMed |
| 17 | 32729019 | Marketing of Tenofovir Disoproxil Fumarate (TDF) Lawsuits and Social Media Misinformation Campaigns' Impact on PrEP Uptake Among Gender and Sexual Minority Individuals. | AIDS Behav | 2021 | https://conductscience.org/library/papers/32729019 | PubMed |
| 18 | 31931525 | Tenofovir Alafenamide for HIV Preexposure Prophylaxis: What Can We DISCOVER About Its True Value? | Ann Intern Med | 2020 | https://conductscience.org/library/papers/31931525 | PubMed |
| 19 | 32702085 | Product Hopping-An Expensive and Wasteful Practice. | JAMA Intern Med | 2020 | https://conductscience.org/library/papers/32702085 | PubMed |
| 20 | 27347468 | Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry. | Springerplus | 2016 | https://conductscience.org/library/papers/27347468 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42989257 | Communication strategies for a future HIV vaccine: a qualitative study on experiences of research staff at the frontlines of recruiting for HIV vaccine clinical trials in the US South. | AIDS Res Ther | 2026 | https://conductscience.org/library/papers/42989257 | PubMed |
| 41324957 | Telemedicine Preexposure Prophylaxis Prescribing From a Large Online US Company. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/41324957 | PubMed |
| 40758923 | Insurance Denials And Cost Sharing For PrEP Among Sexual And Gender Minority People. | Health Aff (Millwood) | 2025 | https://conductscience.org/library/papers/40758923 | PubMed |
| 40323138 | Performance of a whole blood immunoassay for tenofovir detection and correlation with self-reported pre-exposure prophylaxis use in HIV-negative men who have sex with men interested in blood donation. | Transfusion | 2025 | https://conductscience.org/library/papers/40323138 | PubMed |
| 39636888 | Health care providers' decision-making and early adoption of tenofovir alafenamide for HIV preexposure prophylaxis: An inductive qualitative study. | PLoS One | 2024 | https://conductscience.org/library/papers/39636888 | PubMed |
| 39339960 | New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs. | Viruses | 2024 | https://conductscience.org/library/papers/39339960 | PubMed |
| 39222182 | Integrated PrEP and STI Services for Transgender Women in Uganda: Qualitative Findings from a Randomized Trial. | AIDS Behav | 2025 | https://conductscience.org/library/papers/39222182 | PubMed |
| 39095331 | Long-Acting Injectable Pre-Exposure Prophylaxis Perceptions and Preferences Among Transgender and Nonbinary Young Adults in the United States. | Qual Health Res | 2025 | https://conductscience.org/library/papers/39095331 | PubMed |
| 38565913 | The landscape of small-molecule prodrugs. | Nat Rev Drug Discov | 2024 | https://conductscience.org/library/papers/38565913 | PubMed |
| 38352151 | Changes in Glomerular Filtration Rate After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Fumarate for Human Immunodeficiency Virus Preexposure Prophylaxis. | Open Forum Infect Dis | 2024 | https://conductscience.org/library/papers/38352151 | PubMed |
| 38075520 | Overcoming structural barriers to diffusion of HIV pre-exposure prophylaxis. | J Med Access | 2023 | https://conductscience.org/library/papers/38075520 | PubMed |
| 37695583 | Use of Tenofovir Alafenamide Fumarate for HIV Pre-Exposure Prophylaxis and Incidence of Hypertension and Initiation of Statins. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/37695583 | PubMed |
| 37457283 | Analysis of online user discussions on Reddit associated with the transition of use between HIV PrEP therapy. | Front Public Health | 2023 | https://conductscience.org/library/papers/37457283 | PubMed |
| 36880399 | Enzyme-Triggered l-α/d-Peptide Hydrogels as a Long-Acting Injectable Platform for Systemic Delivery of HIV/AIDS Drugs. | Adv Healthc Mater | 2023 | https://conductscience.org/library/papers/36880399 | PubMed |
| 36367995 | Preferences Across Pre-Exposure Prophylaxis Modalities Among Young Men Who Have Sex with Men in the United States: A Latent Class Analysis Study. | AIDS Patient Care STDS | 2022 | https://conductscience.org/library/papers/36367995 | PubMed |
| 36306520 | Validation of HIV Pre-Exposure Prophylaxis (PrEP) Medication Scales with Youth on PrEP: PrEP Confidence Scale and PrEP Difficulties Scale. | AIDS Patient Care STDS | 2022 | https://conductscience.org/library/papers/36306520 | PubMed |
| 35902080 | Health Departments and PrEP: A Missed Opportunity for Public Health. | J Law Med Ethics | 2022 | https://conductscience.org/library/papers/35902080 | PubMed |
| 35507322 | Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women. | AIDS Patient Care STDS | 2022 | https://conductscience.org/library/papers/35507322 | PubMed |
| 35337371 | Considerations and challenges for sex-aware drug repurposing. | Biol Sex Differ | 2022 | https://conductscience.org/library/papers/35337371 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34375141
GET https://conductscience.org/api/papers/v1/34375141/references?page=2